Bethany Grace Armitt-Brewster
Discovery Matters
A collection of stories and insights on matters of discovery that advance life sciences. Brought to you by the curious people at Cytiva.
Author
Bethany Grace Armitt-Brewster
Category
Podcast website
Latest episode
Jul 9, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
72. Cryogenic cold chains and CAR T 24.04.2023 14:56
On the latest episode of Discovery Matters, Dodi and Conor are joined by John Morris, a scientist at the forefront of cryopreservation technology. They discuss the impact of cryopreservation on the development of CAR T therapies, why freezing cells is essential to these treatments, how tracking the samples ensures quality, and the potential for frozen cells to treat solid tumors in the future. Tun...
71. Revived therapies (part 2) - Phage therapy 14.04.2023 20:50
Conor and Dodi explore the new and exciting world of bacteriophage therapy. Join them as they speak to Anton Peleg, Professor of Infectious Diseases and Microbiology and the Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University, about this new, emerging field. Together they discuss how phages, viruses that specifically target bacteria, are being used to fig...
70. Anti-cancer molecules 23.03.2023 14:32
In the latest episode of Discovery Matters, Dodi and Conor are joined by Dr. Bradley Moore from the Scripps Institution of Oceanography to discuss his research into the medical and synthetic implications of using marine microbes to fight aggressive cancers such as glioblastoma. By leveraging salinosporamide A, Dr. Moore proposes that these deep-sea organisms could potentially be scaled up for huma...
69. Never underestimate a cell 13.03.2023 22:54
We should not underestimate cells. Conor and Dodi talk with Dr Brett Kagan who conducted research to understand the brain and test ‘sentient’ brain cells, using the 1970s game, known as ‘Pong’. In another conversation, Professor Petra Levin and Kunaal Joshi explain how they have demonstrated that there is no mythical ‘average’ cell which mimics the stochastic behaviors of any individual cell. At t...
68. CRISPR and molecular aging 23.02.2023 25:31
What do CRISPR and longevity have in common? Not much, except it's all molecular. We speak to two different CEOs focused on improving human health. We begin with Dr Benjamin Oakes, Co-Founder, President, and CEO of Scribe Therapeutics who takes us through the discovery, potential, and possible limitations of CRISPR. Then we are joined by fellow visionary, Kristen Fortney, the CEO and co-founder of...
67. Revived therapies (part 1): Psychedelics 09.02.2023 24:46
Psychedelic treatment is a therapy which is on the rise according to the increasing number of studies on the use of psylocibin, ketamine and MDMA to treat mental health disorders such as PTSD. In this episode, Conor talks to Prof. Eric Vermetten, a psychiatrist who has been working with the military in the Netherlands for the last 25 years helping Dutch armed forces and the uniformed people in the...
66. Getting ÄKTA ready in virtual reality 12.01.2023 25:56
Conor and Dodi try their hand at learning to operate an ÄKTA ready in virtual reality. Their virtual journey takes them to Singapore and Miami, without leaving Sweden, Amersham, and Edinburgh. Join us on a journey into the metaverse. Show notes For more info on using virtual reality for customers: cytiva.com/vr You can view the video version of the episode here , where you can see virtual Dodi and...
65. Best of 2022 22.12.2022 16:10
Mushrooms on Mars, life-saving blood from worms, cell-cultured seafood. It's been a year filled with surprise, serendipity, and everything in between. Conor, Dodi and the podcast team look back on a fascinating year and highlight their favourite interviews and topics of the year. See you in the new year! Show notes More info on Conor’s favorite: What is Quorn mycoprotein? | Quorn More info on Dod...
64. Pain in the body and brain 08.12.2022 20:25
In this episode, we focus on the microbiome and how it is increasingly linked to disease and illness. It seems that this is true for understanding the illness of the body and the brain. Dr Amir Minerbi, the Deputy Director of the Institute for Pain Medicine at Rambam Medical Center in Haifa, Israel talks to us about how the microbiome may hold the secrets of fibromyalgia. This chronic disorder cau...
63. Organ on a chip: part 2 24.11.2022 18:29
In this second episode in a two-part series on organ-on-a-chip technology, we sit down with Christos Michas, R&D scientist and engineer at Curi Bio, and Alice White, professor of mechanical engineering at Boston University. Christos and Alice are taking the organ on a chip to another level with the miniPUMP, a heart on a chip which is the first step in understanding the interaction of therapeu...
62. Organ on a chip: Part 1 10.11.2022 15:04
In this first in a two-part series on organ on a chip technology, we discuss with Jan Turner, formerly part of Safer Medicines Trust, how these organoids can help us move away from the inefficient animal model. Show notes Emulate study on LiverTox - Liver-Chip Publication | Qualifying a human Liver-Chip for predictive toxicology (emulatebio.com) Keywords: chips, drugs, organ, human, model, cells,...
61. Genetic and genomic databases 27.10.2022 26:49
We have a lot of information at our fingertips, so how do we make sense of it all, especially in human health? Conor and Dodi speak to two experts who are making sense of this information overload by creating genetic and genomic databases. Dr Artem Babaian, a computational biologist and now Assistant Professor leading The Laboratory for RNA-Based Lifeforms at the University of Toronto, explains h...
60. The talk on talent 13.10.2022 32:58
Within the life sciences industry, there has been a longstanding conversation around one of the industry’s most difficult challenges. That challenge is talent. In more detail, it is that the access to a global talent pool remains difficult. In this longer than usual conversation, Conor and Dodi speak with Darrin Morrissey, CEO of NIBRT, Anne-Cecile Potmans, general manager of Fast Trak and CDMO se...
59. Microscopic eco-warriors 29.09.2022 22:09
Plastic and pollution are two issues that impact our planet. It would be easy to despair but once again biology has come to save us. The Alper Lab at University of Texas at Austin has engineered a plastic-eating enzyme which can shorten plastic degradation from hundreds of years to 48 hours. We speak to Dr Hal Alper, Professor in Chemical Engineering at UT at Austin, who engineered this heroic enz...
58. Wastewater epidemiology: Something in the wastewater 25.08.2022 19:41
Wastewater-based epidemiology is a relatively new approach to determine the viral make up in any given area. Using chemical analysis of pollutants and biomarkers in raw wastewater, the level of exposure to certain pathogens can be assessed. This technique was used during the pandemic, which has helped realize its potential in public healthcare policy. We speak to Prof. Dominic Frigon, a specialist...
57. Special blood and transplants 30.06.2022 18:07
This episode is all about special blood and transplants. We speak to Jon Adkins, co-founder of XenoTherapeutics, who walks us through their use of xenotransplantation for skin grafts and organ transplantation. We are also joined by Dr. Franck Zal, a marine biologist, CSO and CEO of Hemarina, to discuss the lugworm. His discovery, that the lugworms’ blood is compatible with human blood, means it ca...
56. Understanding and treating Alzheimer’s 16.06.2022 23:06
In this episode, we contemplate the combatting the devastating disease that Alzheimer’s is. According to a recent report by the Alzheimer’s Disease International, an estimated 50 million people are living with dementia due to Alzheimer’s disease. We talk to two experts leading two respective early-stage studies into possible treatments for Alzhemier’s. One study looks at the tackling of tau protei...
55. The injustice of disease burden and access to vaccines 26.05.2022 20:49
The pandemic has been a global issue, which has benefitted from the coming together of industry, pharma, academia, non-governmental and governmental support. What the pandemic has also brought into sharp focus is the global imbalance access to healthcare and health inequity between the Global North and Global South. For this important conversation, we are joined by Professor Linda-Gail Bekker, Chi...
54. Mycoprotein v. cell-cultured seafood 12.05.2022 17:16
We know meat is problematic for the environment, and seafood has its own issues with overfishing, so do we have to wave goodbye to the foods we love? Well, what if we told you that there are substitutes which you can enjoy without sacrificing taste and texture? We start with mycoprotein, in the form of the well-known meat substitute products of Quorn Foods . Tim Finnigan, Chief Scientific Advisor...
53. The future of GMOs 11.05.2022 20:57
According to Jacob Moe-Lange from California Cultured , and Natasha Haveman from the UF Space Plant Lab , genetically modified food is the future. Both discuss the way that food is grown and how that is changing. Jacob takes us through cell-cultured chocolate and the environmental and humanitarian benefits. Natasha forces our gaze upwards to the plant experiments happening in spaceflight condition...
52. The magical world of fungi (part 2) 11.05.2022 15:14
Fungi are amazing in so many ways, and after learning that they could be used to build habitat on Mars, we have this bonus episode to go into home these mushrooms can be used on Earth. Chris Maurer, principal architect at redhouse studios , explains that he has been using mushrooms to make building materials in low-resource environments in Namibia. These materials prove even better than concrete....
51. Women in STEM 11.05.2022 19:05
March is the month of the Woman, and to celebrate International Women’s Day we speak with two agents of change who are passionate about opportunity and diversity within the sciences. Ruchi Sharma, CEO and Founder of Stemnovate Limited , and Sabrina Fleurimé, drug product development scientist and Corporate Partnership Director at BBSTEM , talk to us about what we can all do to become agents of cha...
50. Biomimicry in space exploration 24.02.2022 19:43
Sustained life and colonization in space are closer than ever, and biology holds the key. Biomimetic processes have applications for water filtration and for building homes on Mars. Jörg Vogel, VP of Open Innovation at Aquaporin , discusses how their Aquaporin Inside® Membrane Technology will help filter condensate and urine to make drinking water for astronauts. We are also joined by Chris Maurer...
49. Discovery Makers: Mustapha Bittaye 27.01.2022 16:25
Meet Discovery Maker Mustapha Bittaye, now a senior scientist working on diagnostic assay development at Medicines Discovery Catapult, who previously worked as a postdoctoral researcher at the Jenner Institute helping create the Oxford/AstraZeneca vaccine. Born in The Gambia, a scholarship took Mustapha to the UK to study Microbial Proteomics, and from then onwards he has made truly amazing contri...
48. Discovery Makers: Sebastian Falk 13.01.2022 22:03
What better way to start off 2022 than with a return to our Discovery Makers series. We celebrate discovery by talking to the scientists changing the world one day at a time. This time we are joined by Sebastian Falk. What drives a scientist? Well, according to Sebastian Falk, it is curiosity that drives him. Sebastian is a structural biologist who is leading a research group at the Max Perutz Lab...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.